ROCHESTER, N.Y., May 30, 2012 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) announced today Fiabila S.A., a world leader in private label nail polish manufacturing, has placed orders for NaturalNano's environmentally friendly Halloysite Natural Tubes (HNT) for its new nail polish product line extensions.
NaturalNano CEO James Wemett said," We have developed a new application for our proprietary HNT which Fiabila will use in the manufacturing of nail polish products. The Fiabila order provides a new application and reinforces Fiabila's on-going satisfaction with the technical and commercial results achieved by their nail polish products utilizing HNT from NaturalNano."
Wemett continued, "NaturalNano has a three year exclusive agreement and license to supply Fiabila with HNT for use in their nail polish and nail-care products. These products are available at leading stores including Walmart, Target, CVS and Walgreens and their new market expansion of those products into European Markets.."
About NaturalNano, Inc.:
NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. http://www.naturalnano.com/">www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.